Cannabis & Psychedelics Articles
The Degradation Pathways of Cannabinoids and How to Manage Them – Part 1
In the first of two articles, scientists from Broughton, a regulatory consultancy currently focused on EU and UK cannabis regulation, discuss the susceptibility of cannabinoids to degrade and summarize the main degradation pathways of THC and CBD.
Risk Management Considerations for Cannabis Cultivators
Eric Schneider, the managing director of AlphaRoot, a tech-enabled cannabis insurance broker, explains how cannabis cultivators can maintain their momentum in the industry.
The Process of Pre-Extraction Processing
Jessica McKeil explores the practicalities of pre-extraction protocols.
Meet the Team Who Want To Develop Psychedelics Without the Hallucinations
Technology Networks – Analytical Cannabis’ sister publication – spoke to the team at Delix Therapeutics' to learn how their drugs can keep the benefits of psychedelics compounds while leaving behind the trip.
Adopting Automated Cannabis and Hemp Extraction Solutions
Analytical Cannabis speaks to the extractors using automated solutions to boost their productivity.
The Top 10 Cannabis Stories of 2022
Analytical Cannabis rounds up the year’s top cannabis stories, with a particular focus on research and testing.
Wendi Young on Cannabinoid Testing in Extracts
Young told the recent Analytical Cannabis Expo Europe Online 2022 audience of the importance of stability testing and how to properly conduct shelf stability studies that are effective for a wide variety of cannabis products.
Is Ayahuasca Safe? We Ask a Researcher
Dr. Perkins spoke with Technology Networks – the sister publication of Analytical Cannabis – to provide context on the latest research study and the next steps for the research group.
International Regulatory Developments For Key Psychedelics
Stephen Wright breaks down the lengthy process of getting a psychedelic medicine approved in the US.
